FDA grants fast track designation to drug combo for colorectal cancer
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
FDA grants fast track designation to drug combo for colorectal cancer
Thyroid gland new possible target for prostate cancer treatment
AI model powers skin cancer detection across diverse populations
Factoring in frailty and age to improve pancreatic cancer treatment
Medical, recreational cannabis dispensaries lead to reduced opioid prescriptions
Eco-friendly nanoparticles improve cidofovir’s anticancer and antiviral effects
New study elucidates obesity’s role in fuelling breast cancer progression
Colorectal cancer evades immunotherapy using a dual barrier
FDA approves daratumumab and hyaluronidase-fihj for high-risk smouldering multiple myeloma
Combination immunotherapy helps overcome melanoma treatment resistance
HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model
Hidden HPV-linked cell type may drive early cervical cancer